Clinical trial
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or…
NCT00004084 · Garden State Cancer Center at the Center for Molecular Medicine and Immunology, Other · Completed
Key facts
| NCT number | NCT00004084 |
|---|---|
| Title | Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia |
| Official title | Phase I/II Radioimmunotherapy of Non-Hodgkin's Lymphoma With Radiolabeled Humanized Immu-LL2: Treatment With 90Y-hLL2 IgG |
| Lead sponsor | Garden State Cancer Center at the Center for Molecular Medicine and Immunology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphoma |
| Intervention type | Radiation |
| Interventions | indium In 111 LL2 IgG, yttrium Y 90 epratuzumab |
| Enrollment | 21 |
| Start date | Apr 1, 1998 |
| Primary completion | May 1, 2002 |
| First posted | Apr 15, 2004 |
| Last update posted | Jun 22, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: